First Time Loading...
P

Purple Biotech Ltd
NASDAQ:PPBT

Watchlist Manager
Purple Biotech Ltd
NASDAQ:PPBT
Watchlist
Price: 0.53 USD -2.03% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

PPBT Price Targets Summary
Purple Biotech Ltd

There are no price targets for PPBT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available

PPBT Last Price Targets
Purple Biotech Ltd

The latest public price target was made on Sep 8, 2022 by Matthew Barcus from Chardan Capital , who expects PPBT stock to rise by 1 975% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Matthew Barcus
Chardan Capital
11 USD
Upside 1 975%
1 year ago
Sep 8, 2022
Purple Biotech initiated with a Buy at Chardan
TheFly
Matthew Barcus
Chardan Capital
Price Target 11 USD
Upside/Downside 1 975%
View Source
Purple Biotech Ltd Competitors:
Price Targets
ALIM
Alimera Sciences Inc
124% Upside
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
37% Downside
4502
Takeda Pharmaceutical Co Ltd
19% Upside
TARS
Tarsus Pharmaceuticals Inc
48% Upside
KILITCH
Kilitch Drugs (India) Ltd
34% Upside
002001
Zhejiang Nhu Co Ltd
9% Upside
LQDA
Liquidia Corp
101% Upside
2552
Hua Medicine
126% Upside

Revenue
Forecast

Revenue Estimate
Purple Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Purple Biotech Ltd

Operating Income forecast
is not available for
Purple Biotech Ltd

Net Income
Forecast

Net Income Estimate
Purple Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PPBT's stock price target?
Not Available

PPBT doesn't have any price targets made by Wall Street professionals.